超基因医药
RARE
14.54
-0.63
-4.15%
超基因医药
US · RARE
#3012 按市值排名
上市于 1970
14.54
-0.63
-4.15%
实时 - 追踪5344个代码 - 心跳于330秒前
· 2026-10-16 19:56
最新新闻
-
评级变动
Goldman Sachs Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/10/4
-
公司公告
Rare Element Resources Ltd. | 3: Initial statement of beneficial ownership of securities- Bilant JosefSEC · 2026/10/6
-
评级变动
Ord Minnett Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Sell Rating, Cuts Target Price to $9.82\u5e02\u573a\u8d44\u8baf · 2026/9/29
-
CSL Strikes US$1.6 Billion Licensing Deal for Rare Disease Drug | ASX:CSLProactive Investors · 2026/10/5
-
Mobix Labs Merger Partner Special Project Delivery To Combine With U.S. Rare Earth Company Winner Water Services; Terms Not DisclosedBenzinga · 2026/10/5
-
Ord Minnett Upgrades LYNAS RARE EARTHS LTD(LYSCF.US) to Buy Rating, Raises Target Price to $9.76\u5e02\u573a\u8d44\u8baf · 2026/10/5
-
Bond Selloff Is Opening up Rare Opportunities for Investors. Here Is Where to Look, Says Major Bank.MarketWatch · 2026/10/5
-
评级变动
J.P. Morgan Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $13.17\u5e02\u573a\u8d44\u8baf · 2026/10/3
-
公司公告
American Rare Earths Ltd: CSM Study Strengthens Foundation for U.S. REE SupplyASX · 2026/9/30
-
评级变动
UBS Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $14.55\u5e02\u573a\u8d44\u8baf · 2026/10/2
-
Lynas Rare Earths Price Target Cut 10% to A$18.00/Share by JefferiesDow Jones · 2026/10/5
-
评级变动
William Blair Maintains LYNAS RARE EARTHS LTD SPON ADR EACH REP 1 ORD SHS(LYSDY.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2026/10/1
-
公司公告
Shionogi: Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.JPX · 2026/10/5
-
评级变动
H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $25\u5e02\u573a\u8d44\u8baf · 2026/9/25
-
评级变动
Lynas Rare Earths Price Target Cut 5% T0 A$19.00/Share by MacquarieDow Jones · 2026/10/2
-
评级变动
Lynas Rare Earths Price Target Cut 6.7% to A$21.00/Share by UBSDow Jones · 2026/10/2
-
评级变动
J.P. Morgan Remains a Buy on Lynas Rare Earths (LYSCF)TipRanks · 2026/10/3
-
公司公告
JX Advanced Metals: Notice Regarding the Agreement on a Joint Study for Entering the Rare Earth Refining Business with Tronox Co., Ltd.JPX · 2026/9/29
-
评级变动
Macquarie Maintains AMERICAN RARE EARTHS LTD(ARRNF.US) With Buy Rating, Cuts Target Price to $0.38\u5e02\u573a\u8d44\u8baf · 2026/10/1
-
公司公告
Xiamen Tungsten Co., Ltd.: Notice Regarding the Acceptance of the Application for a Public Offering of Shares and Listing on the Beijing Stock Exchange by Its Controlling Subsidiary, Jinlong Rare EarthSZSI · 2026/10/1
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:56:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
超基因医药 讨论区 0 条评论